{"transactions":[{"id":719930,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-02T21:17:53.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":1112,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26709,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":1112},"source":{"system":"sec-edgar","filing":"0001061983-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000072/form4.xml","form_type":"4"}},{"id":719929,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:17:53.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":1112,"price":87.79,"value":97622.48,"ownership":{"direct":true},"balance_after":63221,"source":{"system":"sec-edgar","filing":"0001061983-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000072/form4.xml","form_type":"4"}},{"id":719928,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:17:53.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":1112,"price":48.51,"value":53943.12,"ownership":{"direct":true},"balance_after":64333,"source":{"system":"sec-edgar","filing":"0001061983-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000072/form4.xml","form_type":"4"}},{"id":724896,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":1113,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27821,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":1113},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724895,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31197,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724894,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6011,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":188},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724893,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":1113,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28934,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":1113},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724892,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":2817,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6199,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":2817},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724891,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":9307,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32019,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":9307},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724890,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":23370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30047,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":23370},"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724889,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":38730,"price":82.3,"value":3187479.0,"ownership":{"direct":true},"balance_after":63221,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724888,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":1113,"price":48.51,"value":53991.63,"ownership":{"direct":true},"balance_after":101951,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724887,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":822,"price":44.36,"value":36463.92,"ownership":{"direct":true},"balance_after":100838,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724886,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":188,"price":44.36,"value":8339.68,"ownership":{"direct":true},"balance_after":100016,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724885,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":1113,"price":48.51,"value":53991.63,"ownership":{"direct":true},"balance_after":99828,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724884,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":2817,"price":44.36,"value":124962.12,"ownership":{"direct":true},"balance_after":98715,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724883,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":9307,"price":44.36,"value":412858.52,"ownership":{"direct":true},"balance_after":95898,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724882,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T22:05:24.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":23370,"price":48.51,"value":1133678.7,"ownership":{"direct":true},"balance_after":86591,"source":{"system":"sec-edgar","filing":"0001061983-26-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000071/form4.xml","form_type":"4"}},{"id":724881,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":823,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39681,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":823},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724880,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8640,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":188},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724879,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":1113,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52304,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":1113},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724878,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40504,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724877,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8828,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":188},"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724876,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":3134,"price":85,"value":266390.0,"ownership":{"direct":true},"balance_after":63221,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724875,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":823,"price":44.36,"value":36508.28,"ownership":{"direct":true},"balance_after":66355,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724874,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":188,"price":44.36,"value":8339.68,"ownership":{"direct":true},"balance_after":65532,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724873,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":1113,"price":48.51,"value":53991.63,"ownership":{"direct":true},"balance_after":65344,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724872,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":822,"price":44.36,"value":36463.92,"ownership":{"direct":true},"balance_after":64231,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":724871,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-29T21:23:39.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":true,"shares":188,"price":44.36,"value":8339.68,"ownership":{"direct":true},"balance_after":63409,"source":{"system":"sec-edgar","filing":"0001061983-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000070/form4.xml","form_type":"4"}},{"id":747142,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-08T21:49:24.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":3570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":3570,"derivative":{"exercise_price":20.22,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":3570},"source":{"system":"sec-edgar","filing":"0001193125-26-262172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000119312526262172/ownership.xml","form_type":"4"}},{"id":747141,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T21:49:24.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":22870,"source":{"system":"sec-edgar","filing":"0001193125-26-262172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000119312526262172/ownership.xml","form_type":"4"}},{"id":792912,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-05T20:18:05.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":23906,"price":76.87,"value":1837654.22,"ownership":{"direct":true},"balance_after":63221,"source":{"system":"sec-edgar","filing":"0001061983-26-000049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000049/form4.xml","form_type":"4"}},{"id":796311,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-01T21:26:21.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years commencing on January 2, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The options were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":5200,"derivative":{"exercise_price":22.06,"expiration_date":"2036-04-29","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001193125-26-201749","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000119312526201749/ownership.xml","form_type":"4"}},{"id":796310,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T21:26:21.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":12300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments on January 2, 2027, January 2, 2028 and January 2, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. The RSUs were granted in connection with the Reporting Person's service on the Issuer's board of directors and reflect the value the Reporting Person is entitled to pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":22300,"source":{"system":"sec-edgar","filing":"0001193125-26-201749","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000119312526201749/ownership.xml","form_type":"4"}},{"id":836094,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T21:46:09.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":4935,"price":62.15,"value":306710.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Company compelled sell-to-cover transaction to satisfy tax withholding obligations attributable to RSU vesting."}],"balance_after":87127,"source":{"system":"sec-edgar","filing":"0001061983-26-000029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000029/form4.xml","form_type":"4"}},{"id":840054,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-03-17T20:05:26.000Z","date":"2026-03-15","kind":"grant","planned":false,"acquired":true,"shares":29480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award comprised of stock options that vest in 48 equal monthly installments, subject to officer's continued employment with the company on each vesting date. Stock options are subject to the company's Amended and Restated 2004 Equity Incentive Plan."}],"balance_after":29480,"derivative":{"exercise_price":60.06,"exercise_date":"2026-04-15","expiration_date":"2036-03-14","underlying":"Common Stock","underlying_shares":29480},"source":{"system":"sec-edgar","filing":"0001061983-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000021/form4.xml","form_type":"4"}},{"id":840053,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-03-17T20:05:26.000Z","date":"2026-03-15","kind":"grant","planned":false,"acquired":true,"shares":1665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Annual equity award comprised of stock options that vest in 48 equal monthly installments, subject to officer's continued employment with the company on each vesting date. Stock options are subject to the company's Amended and Restated 2004 Equity Incentive Plan."}],"balance_after":1665,"derivative":{"exercise_price":60.06,"exercise_date":"2026-04-15","expiration_date":"2036-03-14","underlying":"Common Stock","underlying_shares":1665},"source":{"system":"sec-edgar","filing":"0001061983-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000021/form4.xml","form_type":"4"}},{"id":840052,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:05:26.000Z","date":"2026-03-15","kind":"grant","planned":false,"acquired":true,"shares":20646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual equity award comprised of restricted stock units (\"RSUs\") that convert on a 1:1 basis for shares of our common stock. RSUs vest, subject to the officer's continued employment with the company, as follows: 40% of the RSUs on the 1-year anniversary of the grant date, an additional 40% of the RSUs on the 2-year anniversary of the grant date, and the final 20% of the RSUs on the 3-year anniversary of the grant date. RSUs are subject to the company's Amended and Restated 2004 Equity Incentive Plan."}],"balance_after":92062,"source":{"system":"sec-edgar","filing":"0001061983-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198326000021/form4.xml","form_type":"4"}},{"id":948976,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:10:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":8.93,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193125-26-004433","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000119312526004433/ownership.xml","form_type":"4"}},{"id":948975,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:10:04.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001193125-26-004433","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000119312526004433/ownership.xml","form_type":"4"}},{"id":959058,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:03:39.000Z","date":"2025-12-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":805,"price":62.72,"value":50489.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld for tax withholding upon vesting of performance shares."}],"balance_after":71416,"source":{"system":"sec-edgar","filing":"0001061983-25-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198325000053/form4.xml","form_type":"4"}},{"id":959057,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:03:39.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":2152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Performance shares earned upon achievement of performance goal. Shares vested immediately."}],"balance_after":72221,"source":{"system":"sec-edgar","filing":"0001061983-25-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198325000053/form4.xml","form_type":"4"}},{"id":959056,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:03:39.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":2152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Performance shares earned upon achievement of performance goal. Shares remain subject to 1-year time vesting requirement."}],"balance_after":70069,"source":{"system":"sec-edgar","filing":"0001061983-25-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198325000053/form4.xml","form_type":"4"}},{"id":979704,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T21:25:28.000Z","date":"2025-12-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1560,"price":65.02,"value":101431.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell to cover transaction for tax withholding upon vesting of Performance Stock Units granted earned on December 2, 2024."}],"balance_after":67917,"source":{"system":"sec-edgar","filing":"0001061983-25-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000106198325000046/form4.xml","form_type":"4"}},{"id":1126575,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:02:50.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4965,"price":31.21,"value":154957.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions represent withholding of restricted stock units upon vesting of 13,874 restricted stock units. Reporting person received 8,909 net shares of common stock after the withholding transaction.."}],"balance_after":69477,"source":{"system":"sec-edgar","filing":"0001127602-25-016416","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760225016416/form4.xml","form_type":"4"}},{"id":1202416,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-03-18T20:24:58.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":41326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Lee's continued employment with the company on the scheduled vesting date."}],"balance_after":41326,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":41326},"source":{"system":"sec-edgar","filing":"0001127602-25-009770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760225009770/form4.xml","form_type":"4"}},{"id":1202415,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2025-03-18T20:24:58.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":9016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Lee's continued employment with the company on the scheduled vesting date."}],"balance_after":9016,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":9016},"source":{"system":"sec-edgar","filing":"0001127602-25-009770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760225009770/form4.xml","form_type":"4"}},{"id":1202414,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T20:24:58.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":32687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that convert to shares of common stock on a 1:1 basis upon vesting. 40% of the RSUs will vest on the 1-year anniversary of the date of grant; an additional 40% of the RSUs will vest on the 2-year anniversary of the date of grant; and the final 20% of the RSUs will vest on the 3-year anniversary of the date of grant, in each case subject to Mr. Lee's continued employment with the company on the scheduled vesting date."}],"balance_after":74442,"source":{"system":"sec-edgar","filing":"0001127602-25-009770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760225009770/form4.xml","form_type":"4"}},{"id":1342127,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T21:30:58.000Z","date":"2024-12-03","kind":"grant","planned":false,"acquired":true,"shares":4304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction represents shares of PSUs whose performance condition was satisfied but that remain subject to time-based vesting.  These PSUs to vest in full December 3, 2025."}],"balance_after":41755,"source":{"system":"sec-edgar","filing":"0001127602-24-028721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760224028721/form4.xml","form_type":"4"}},{"id":1342126,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T21:30:58.000Z","date":"2024-12-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1536,"price":51.51,"value":79119.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents withholding of shares to satisfy grantee's tax obligations in connection with vesting PSUs."}],"balance_after":37451,"source":{"system":"sec-edgar","filing":"0001127602-24-028721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760224028721/form4.xml","form_type":"4"}},{"id":1342125,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T21:30:58.000Z","date":"2024-12-03","kind":"grant","planned":false,"acquired":true,"shares":4303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents gross shares of common stock received by grantee upon vesting of Performance Stock Units (\"PSUs\")."}],"balance_after":38987,"source":{"system":"sec-edgar","filing":"0001127602-24-028721","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760224028721/form4.xml","form_type":"4"}},{"id":1495912,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-06-03T21:07:36.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":53417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Comprised of non-statutory stock options to purchase shares of common stock and vesting as follows: 25% on the 1-year anniversary of the grant date and the remaining 75% vesting in equal monthly installments over the subsequent 36 months from the 1-year anniversary of the grant date, in each case subject to continued employment."}],"balance_after":53417,"derivative":{"exercise_price":48.51,"exercise_date":"2025-06-02","expiration_date":"2034-05-30","underlying":"Common Stock","underlying_shares":53417},"source":{"system":"sec-edgar","filing":"0001127602-24-017329","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760224017329/form4.xml","form_type":"4"}},{"id":1495911,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"officer":true,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-03T21:07:36.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":34684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units convertible into shares of common stock on a 1-for-1 basis and vesting as follows: 40% on the 1-year anniversary of the grant date, an additional 40% on the 2-year anniversary of the grant date, and the remaining 20% on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment."}],"balance_after":34684,"source":{"system":"sec-edgar","filing":"0001127602-24-017329","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000112760224017329/form4.xml","form_type":"4"}},{"id":1558965,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-28T16:18:57.000Z","date":"2024-03-27","kind":"sale","planned":false,"acquired":false,"shares":6008,"price":9.8875,"value":59404.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":100492,"source":{"system":"sec-edgar","filing":"0001628280-24-013555","document":"wk-form4_1711642726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000162828024013555/wk-form4_1711642726.xml","form_type":"4"}},{"id":1620999,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-27T00:32:19.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2025, and the remainder vest in 36 equal monthly\ninstallments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":10.11,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001628280-24-006983","document":"wk-form4_1708993922.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000162828024006983/wk-form4_1708993922.xml","form_type":"4"}},{"id":1620998,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-27T00:32:19.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":106500,"source":{"system":"sec-edgar","filing":"0001628280-24-006983","document":"wk-form4_1708993922.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000162828024006983/wk-form4_1708993922.xml","form_type":"4"}},{"id":1936204,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T21:49:45.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":133000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on March 27, 2024, and the remainder vest in 36 equal monthly installments thereafter."}],"balance_after":133000,"derivative":{"exercise_price":23.01,"expiration_date":"2033-03-26","underlying":"Common Stock","underlying_shares":133000},"source":{"system":"sec-edgar","filing":"0001209191-23-021548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000120919123021548/doc4.xml","form_type":"4"}},{"id":1936203,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-29T21:49:45.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":66500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":66500,"source":{"system":"sec-edgar","filing":"0001209191-23-021548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000120919123021548/doc4.xml","form_type":"4"}},{"id":2964889,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-01T00:46:14.000Z","date":"2020-11-25","kind":"tax_withholding","acquired":false,"shares":5042,"price":9.77,"value":49260.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying the portion of the restricted stock unit grant that vested on November 25, 2020 surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on November 25, 2020 of $9.77/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the \"2018 EIP, as amended\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: 9,540 shares resulting from the November 25, 2020 vesting of Reporting Person's November 25, 2019 restricted stock unit (\"RSU\") grant; 29,168 shares subject to such RSU grant that will vest in two remaining annual installments on November 25, 2021 and 2022, resulting in such RSU grant being vested in full on the third (3rd) anniversary of the grant date; 50,000 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on February 25, 2020. All such RSUs vest with respect to 1/3rd of the shares in each respective RSU grant in three equal annual installments over the three-year period measured from the dates of grant, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended."}],"balance_after":88708,"source":{"system":"sec-edgar","filing":"0001209191-20-060811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000120919120060811/doc4.xml","form_type":"4"}},{"id":3247523,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right-to-Buy)","published_at":"2020-02-27T00:31:52.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":100500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 25, 2020 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":100500,"derivative":{"exercise_price":6.8,"expiration_date":"2030-02-24","underlying":"Common Stock","underlying_shares":100500},"source":{"system":"sec-edgar","filing":"0001209191-20-013230","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000120919120013230/doc4.xml","form_type":"4"}},{"id":3247522,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-27T00:31:52.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 50,000 shares subject to restricted stock units granted on February 25, 2020 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates."}],"balance_after":93750,"source":{"system":"sec-edgar","filing":"0001209191-20-013230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000120919120013230/doc4.xml","form_type":"4"}},{"id":3359431,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-26T21:15:10.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":262000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the November 25, 2019 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date."}],"balance_after":262000,"derivative":{"exercise_price":10.35,"expiration_date":"2029-11-24","underlying":"Common Stock","underlying_shares":262000},"source":{"system":"sec-edgar","filing":"0001209191-19-058104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000120919119058104/doc4.xml","form_type":"4"}},{"id":3359430,"issuer":{"id":7038,"kind":"organization","name":"SANGAMO THERAPEUTICS, INC"},"owners":[{"id":33455,"kind":"person","name":"Lee Sung","position":1,"cik":"0001793200","reported_name":"Lee Sung","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-11-26T21:15:10.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 43,750 shares of common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person on November 25, 2019. The RSUs will vest with respect to 1/3rd of the shares in three equal annual installments over the three-year period measured from the date of grant, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":43750,"source":{"system":"sec-edgar","filing":"0001209191-19-058104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1793200/000120919119058104/doc4.xml","form_type":"4"}}]}